San Diego, California — According to state and local economic development sources Pacira BioSciences, Inc. plans to invest $2,838,516.00 to build out 33,006 square feet of new space in San Diego. The company plans to occupy the new space at 10410 Science Center Dr in San Diego, on or about October 1, 2020. According to the company website Pacira BioSciences, Inc. is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.

To learn more about Pacira BioSciences, Inc., visit http://www.pacira.com/

Company Contact:
David Stack, Chief Executive Officer
https://www.linkedin.com/in/dave-stack-0321479/
973-254-3560

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved